AMERICAN ACADEMY OF CLINICAL TOXICOLOGY (EIN 741686373) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

JEANNA MARRAFFA

Phone

7035569222

Tax Period

2023-07-01 to 2024-06-30

AMERICAN ACADEMY OF CLINICAL TOXICOLOGY, founded in 1968, is a small nonprofit in the Diseases & Disorders sector that reported $404K in total revenue in fiscal year 2018. Revenue decreased 18% compared to the prior year. Expenses of $506K exceeded revenue, resulting in a 25% operating deficit.

Mission

THE AMERICAN ACADEMY OF CLINICAL TOXICOLOGY (THE ACADEMY) WAS ESTABLISHED AS A NOT-FOR-PROFIT MULTI-DISCIPLINARY ORGANIZATION UNITING SCIENTISTS AND CLINICIANS IN THE ADVANCEMENT OF RESEARCH, EDUCATION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY CHEMICALS, DRUGS AND TOXINS.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $14,502

Program Service Revenue $528,847

Investment Income $31,373

Other Revenue $0

TOTAL REVENUE $574,722

Expense Breakdown

Grants Paid $22,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $388,530

Other Expenses $428,117

TOTAL EXPENSES $450,117

Year-over-Year Comparison

	2023	2022	Change
Revenue	$574,722	$442,062	+0.3%
Expenses	$450,117	$511,722	-0.1%
Net Income	$124,605	$-69,660	-2.8%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHRISTOPHER HOYTE MD FAACT	PRESIDENT	7.00	Officer Director	$0	$0	$0
JEANNA MARRAFFA PHARMD FAACT	PRESIDENT-ELECT	2.00	Officer Director	$0	$0	$0
KIRK CUMPSTON DO FAACT	IMMEDIATE PAST-PRESIDENT	2.00	Officer Director	$0	$0	$0
JOHN GREENE SHEPHERD PHARMD DABAT	TREASURER	1.50	Officer Director	$0	$0	$0
JILLIAN THEOBALD MD PHD	SECRETARY	2.00	Officer Director	$0	$0	$0
JON B COLE MD FAACT	TRUSTEE	0.50	Director	$0	$0	$0
ANN ARENS MD	TRUSTEE	0.50	Director	$0	$0	$0
SEAN BRYANT MD	TRUSTEE	0.50	Director	$0	$0	$0
ALEXANDRA FUNK PHARMD DABAT FAACT	TRUSTEE	0.50	Director	$0	$0	$0
MARK SU MD MPH	TRUSTEE	0.50	Director	$0	$0	$0
BRYAN WILSON	TRUSTEE	0.50	Director	$0	$0	$0
JIM MOWRY PHARMD DABAT FAACT	TRUSTEE	0.50	Director	$0	$0	$0
RANA BIARY MD	TRUSTEE	0.50	Director	$0	$0	$0
BRANDON WILLS DO MS FAACT	TRUSTEE	0.50	Director	$0	$0	$0
CHRISTINE MURPHY MD	TRUSTEE	0.50	Director	$0	$0	$0
KRISTIN REINAKE PHARMD DABAT	TRUSTEE	0.50	Director	$0	$0	$0
JESSICA KONRATH ED	EXECUTIVE DIRECTOR	8.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$574,722	$450,117	$1,155,301	$124,605
2023	$442,062	$511,722	$1,123,493	$-69,660
2022	$576,014	$385,159	$1,046,841	$190,855
2021	$469,498	$388,956	$968,910	$80,542
2019	$458,558	$396,328	$873,651	$62,230
2018	$403,851	$505,906	$812,294	$-102,055

AMERICAN ACADEMY OF CLINICAL TOXICOLOGY